LAS VEGAS, July 8, 2019 /PRNewswire/ -- As part of its commitment to address the addiction epidemic, the Voices Project is convening the first ever Mobilize Recovery conference in

LAKEWOOD, Colo., July 8, 2019 /PRNewswire/ -- In response to increased demand for its infusion services, Colorado-based Multispecialty Physician Partners ("MPP"), is announcing further expansion within the Dallas/Ft. Worth metroplex, designed to provide the additional capacity required for its anticip

KING OF PRUSSIA, Pa., July 8, 2019 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its second quarter ended June 30, 2019 after the market closes on Thursday, July 25, 2019.  There will be a conference call for investors and analysts at

SOUTH SAN FRANCISCO, July 8, 2019 /PRNewswire/ -- Satsuma Pharmaceuticals, Inc. ("Satsuma" or "the Company"), a late-stage biopharmaceutical company developing STS101, (dihydroergotamine (DHE) nasal powder) for the acute treatment of migraine, today announced that a poster describing pharmacokinetic (PK), safety and tolerability data from a Phase 1 trial of STS101 w

DUBLIN, July 8, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has completed the previously announced divestiture of its Animal Health business to PetIQ (NASDAQ: PETQ) for $185 million.

BOSTON, July 8, 2019 /PRNewswire/ -- This month, Beacon Hill Pharma opened in Colorado Springs, joining Beacon Hill Technologies. With this addition, the Pharma division now operates in five Beacon Hill locations including Boston – North, Chi

SAN DIEGO, July 8, 2019 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it will report second quarter financial results after the Nasdaq market closes on Monday, July 29, 2019. Neurocrine will then host a conference call and webcast to discuss its financial results and provide a Company update that day a

KELOWNA, BC, July 8, 2019 /PRNewswire/ - Valens GroWorks Corp. (CSE: VGW) (OTC: VGWCF) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality te

THOUSAND OAKS, Calif., July 8, 2019 /PRNewswire/ -- The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, Australia, Canada, Hong Kon

MASHPEE, Mass., July 8, 2019 /PRNewswire/ -- Environ® Skin Care was voted a "Top Medical Skin Care" company in the Aesthetic Everything® Awards. This year's 2019 Aesthet